C No More: Mobile hepatitis C testing and treatment for people on community corrections orders

Not Applicable

Recruiting

• Conditions: hepatitis C; Public Health - Health service research; Infection - Other infectious diseases; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12623001043628
• Lead Sponsor: St Vincent's Hospital Melbourne (Limited)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-09-27
• Last Update Posted: 9 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

1. Aged at least 18 years;
2. Consenting to point-of-care fingerstick testing for hepatitis C;
3. Consent to provide full name, date of birth, contact details, Medicare number and general practitioner details (if available);
4. Not currently engaged in treatment for hepatitis C infection;

Exclusion Criteria

1.. Unable or unwilling to undergo point-of-care hepatitis C RNA testing.
2. Unable or unwilling to provide informed consent
There are no other exclusion criteria for testing for hepatitis C infection, however there may be contraindication or caution to hepatitis C DAA treatment including:
a.receiving medications which are contraindicated to the co-administration of DAAs or at risk of significant drug-drug interaction;
b.pregnant or breastfeeding at the time of commenced of DAA therapy;
c.Individuals with decompensated chronic liver disease
These individuals will be referred to St Vincent’s Hospital for specialist consultation review.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of people approached who were tested for hepatitis C using point-of-care testing technologies, captured through a daily log kept by the study team.[ 18 months post intervention commencement];Proportion of participants testing positive for current hepatitis C infection who are initiated on direct-acting antiviral treatment, captured through clinical data collected on REDCap by the study nurse.[ 24 months post-intervention commencement]